Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 25, 2022 at 11:45 am
Share
Baotou Dongbao Bio-Tech Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 228.17 million compared to CNY 138.18 million a year ago. Revenue was CNY 228.17 million compared to CNY 138.18 million a year ago. Net income was CNY 23.72 million compared to CNY 4.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.0089 a year ago. Diluted earnings per share from continuing operations was CNY 0.04 compared to CNY 0.0089 a year ago.
Baotou Dongbao Bio-Tech Co., Ltd is principally engaged in the research, development, manufacture and distribution of gelatin series products and low molecular mass collagen. The Company primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The Company distributes its products in both domestic and overseas markets, with domestic markets as its major markets.
BAOTOU DONGBAO BIO-TECH CO.,LTD 
